TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: Sirtuin 1 (SIRT1) is a NAD-dependent HDAC that acts on the nonhistone target p53 in CD34+ CML cells and has been associated with leukemogenesis and the persistence of CML LSCs.